DNTH

DIANTHUS THERAPEUTICS INC

Healthcare | Mid Cap

-$1.22

EPS Forecast

$0.54

Revenue Forecast

The company already released most recent quarter's earnings. We will publish our AI's next quarter's forecast around 2026-07-01

Proximilar's AI forecasts

EPS Forecast:

-$1.22

Revenue Forecast:

$0.54

EPS Surprise Forecast:

-$0.055

Revenue Surprise Forecast:

$0

Post-release price volatility - High

Post-release Overnight Move:

±8.0%

Post-release 1-week Move:

±

Odds of beating consensus

Probability of beating EPS consensus:

42%

Probability of beating revenue consensus:

52%

Probability of beating both EPS & revs consensus:

28%

Probability of missing both EPS & revs consensus:

35%

Surprise rating (from -5 to 5)

How unusually large is the +/- surprise we forecast:

-4

Beta (β)

Forward Looking Beta (β):

1.99

Earnings volatility

EPS standard deviation:

$0.45

Revenue standard deviation:

$9

As % of share price:

0.56% MEDIUM

As % of market cap:

0.25% LOW

Confidence intervals and percentiles

EPS 95th %ile:

-$0.63

Revenue 95th %ile:

$12

EPS 75th %ile:

-$1.06

Revenue 75th %ile:

$4

EPS 25th %ile:

-$1.35

Revenue 25th %ile:

-$2

EPS 5th %ile:

-$1.71

Revenue 5th %ile:

-$9

Correlation of surprises (strength of relationship)

Correlation between EPS & revenue surprises:

41% HIGH

Earnings sensitivity to revenue surprises (slope of regression line)

Expected % of revenue surprise going to EPS:

94% VERY HIGH

Stock's bid-ask spread

Bid-ask per $10K:

$28

Bid-ask per Share:

$0.22